Constellation Software Inc
DUS:W9C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Constellation Software Inc
DUS:W9C
|
CA |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
F:PJX
|
BR |
|
M
|
Mainova AG
XMUN:MNV6
|
DE |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
|
T
|
Terumo Corp
F:TUO
|
JP |
|
Severn Trent PLC
F:SVT
|
UK |
Wall St Price Targets
W9C Price Targets Summary
Constellation Software Inc
According to Wall Street analysts, the average 1-year price target for W9C is 4 030.2 EUR with a low forecast of 3 299.84 EUR and a high forecast of 5 549.38 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is W9C's stock price target?
Price Target
4 030.2
EUR
According to Wall Street analysts, the average 1-year price target for W9C is 4 030.2 EUR with a low forecast of 3 299.84 EUR and a high forecast of 5 549.38 EUR.
What is the Revenue forecast for Constellation Software Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 8 years is 11%.
What is the Operating Income forecast for Constellation Software Inc?
Projected CAGR
14%
Over the last 14 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 8 years is 14%.
What is the Net Income forecast for Constellation Software Inc?
Projected CAGR
98%
Over the last 14 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 98%.
